RPG Life Sciences Limited Financial Ratios
RPGLIFE · Healthcare · Current price ₹2,923.5
P/E ratio
42.0x
P/B ratio
8.0x
ROE
19.0%
ROCE
24.8%
Debt / Equity
0.03
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 42.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 8.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 19.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 24.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.03 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with RPG Life Sciences Limited's latest numbers.
RPG Life Sciences Limited profitability
RPG Life Sciences Limited generates a return on equity of 19.0% and a return on capital employed of 24.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.03 and a P/E of 42.0x, RPG Life Sciences Limited is conservatively financed. Our overall business-quality score for the company is 5.6 / 10.
Understand the ratios
More on RPG Life Sciences Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.